These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 10231815)
21. Psychopathology of panic attacks in panic disorder. Uhlenhuth EH; Leon AC; Matuzas W J Affect Disord; 2006 May; 92(1):55-62. PubMed ID: 16448702 [TBL] [Abstract][Full Text] [Related]
22. Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia. Mavissakalian MR; Perel JM; Talbott-Green M; Sloan C Biol Psychiatry; 1998 Jun; 43(11):848-54. PubMed ID: 9611676 [TBL] [Abstract][Full Text] [Related]
23. Predictors and time course of response among panic disorder patients treated with cognitive-behavioral therapy. Aaronson CJ; Shear MK; Goetz RR; Allen LB; Barlow DH; White KS; Ray S; Money R; Saksa JR; Woods SW; Gorman JM J Clin Psychiatry; 2008 Mar; 69(3):418-24. PubMed ID: 18278989 [TBL] [Abstract][Full Text] [Related]
24. Nomophobia: the mobile phone in panic disorder with agoraphobia: reducing phobias or worsening of dependence? King AL; Valença AM; Nardi AE Cogn Behav Neurol; 2010 Mar; 23(1):52-4. PubMed ID: 20299865 [TBL] [Abstract][Full Text] [Related]
25. The use of the Panic and Agoraphobia Scale in a clinical trial. Bandelow B; Brunner E; Broocks A; Beinroth D; Hajak G; Pralle L; Rüther E Psychiatry Res; 1998 Jan; 77(1):43-9. PubMed ID: 10710174 [TBL] [Abstract][Full Text] [Related]
26. Comorbid panic disorder and major depression: implications for cognitive-behavioral therapy. McLean PD; Woody S; Taylor S; Koch WJ J Consult Clin Psychol; 1998 Apr; 66(2):240-7. PubMed ID: 9583327 [TBL] [Abstract][Full Text] [Related]
27. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. Barlow DH; Gorman JM; Shear MK; Woods SW JAMA; 2000 May; 283(19):2529-36. PubMed ID: 10815116 [TBL] [Abstract][Full Text] [Related]
28. Measurement of panic disorder by a modified panic diary. de Beurs E; Chambless DL; Goldstein AJ Depress Anxiety; 1997; 6(4):133-9. PubMed ID: 9559282 [TBL] [Abstract][Full Text] [Related]
29. Agoraphobia and panic attacks complicated by primary aldosteronism improved by treatment with eplerenone: a case report. Kijima R; Tesen H; Igata R; Okamoto N; Yoshimura R BMC Psychiatry; 2023 Oct; 23(1):787. PubMed ID: 37891534 [TBL] [Abstract][Full Text] [Related]
30. [Early detection and treatment of panic disorder with or without agoraphobia: update]. Foldes-Busque G; Marchand A; Landry P Can Fam Physician; 2007 Oct; 53(10):1686-93. PubMed ID: 17934032 [TBL] [Abstract][Full Text] [Related]
31. Fear of Fear and Broad Dimensions of Psychopathology over the Course of Cognitive Behavioural Therapy for Panic Disorder with Agoraphobia in Japan. Ogawa S; Kondo M; Ino K; Ii T; Imai R; Furukawa TA; Akechi T East Asian Arch Psychiatry; 2017 Dec; 27(4):150-5. PubMed ID: 29259145 [TBL] [Abstract][Full Text] [Related]
32. Emotion-focused psychotherapy for patients with panic disorder. Shear MK; Houck P; Greeno C; Masters S Am J Psychiatry; 2001 Dec; 158(12):1993-8. PubMed ID: 11729015 [TBL] [Abstract][Full Text] [Related]
33. Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia. Mavissakalian MR; Perel JM Arch Gen Psychiatry; 1999 Sep; 56(9):821-7. PubMed ID: 12884888 [TBL] [Abstract][Full Text] [Related]
34. [Panic disorder and agoraphobia: what is effective?]. Bandelow B; Sievert K; Röthemeyer M; Hajak G; Broocks A; Rüther E Fortschr Neurol Psychiatr; 1995 Nov; 63(11):451-64. PubMed ID: 8575719 [TBL] [Abstract][Full Text] [Related]
35. A randomized clinical trial of cognitive behavioral therapy and interpersonal psychotherapy for panic disorder with agoraphobia. Vos SP; Huibers MJ; Diels L; Arntz A Psychol Med; 2012 Dec; 42(12):2661-72. PubMed ID: 22717019 [TBL] [Abstract][Full Text] [Related]
36. Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale. Bandelow B Int Clin Psychopharmacol; 1995 Jun; 10(2):73-81. PubMed ID: 7673659 [TBL] [Abstract][Full Text] [Related]
37. Discussion of "methodological controversies in the treatment of panic disorder". Klein DF Behav Res Ther; 1996; 34(11-12):849-53; discussion 855-63. PubMed ID: 8990537 [No Abstract] [Full Text] [Related]
38. The effect of a combined versus a conventional cognitive-behavioral therapy on quality of life for comorbid panic disorder with agoraphobia and generalized anxiety disorder: preliminary results. Primiano S; Marchand A; Gosselin P; Langlois F; Bouchard S; Bélanger C; Labrecque J; Dugas M; Dupuis G Behav Modif; 2014 Jan; 38(1):3-24. PubMed ID: 24068750 [TBL] [Abstract][Full Text] [Related]
39. Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Otto MW; Pollack MH; Penava SJ; Zucker BG Behav Res Ther; 1999 Aug; 37(8):763-70. PubMed ID: 10452176 [TBL] [Abstract][Full Text] [Related]
40. Psychiatric treatment received by primary care patients with panic disorder with and without agoraphobia. Marcks BA; Weisberg RB; Keller MB Psychiatr Serv; 2009 Jun; 60(6):823-30. PubMed ID: 19487354 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]